| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
3,492,000 |
| Market
Cap: |
4.68(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.23 - $6.49 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile BioRestorative Therapies is a life sciences company focused on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult stem cells. Co.'s cell therapy candidate, BRTX-100, is a product formulated from autologous (or person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. Co. is developing a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue. Co. has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
8,308 |
288,308 |
326,849 |
393,260 |
| Total Buy Value |
$10,229 |
$378,507 |
$450,343 |
$693,135 |
| Total People Bought |
1 |
2 |
3 |
4 |
| Total Buy Transactions |
2 |
6 |
17 |
61 |
| Total Shares Sold |
0 |
528 |
528 |
6,486 |
| Total Sell Value |
$0 |
$994 |
$994 |
$21,280 |
| Total People Sold |
0 |
1 |
1 |
2 |
| Total Sell Transactions |
0 |
2 |
2 |
4 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Broadrick Dale |
10% Owner |
– – • |
2022-06-21 |
4 |
B |
$3.68 |
$368 |
D/D |
100 |
295,473 |
2.37 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-06-17 |
4 |
B |
$3.80 |
$2,282 |
D/D |
600 |
295,373 |
2.37 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-06-16 |
4 |
B |
$3.81 |
$7,611 |
D/D |
2,000 |
294,773 |
2.37 |
- |
|
| Alstodt Lance |
President, CEO, COB |
• • – |
2022-06-16 |
4 |
B |
$3.73 |
$2,238 |
D/D |
600 |
180,921 |
2.73 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-06-15 |
4 |
B |
$3.72 |
$4,464 |
D/D |
1,200 |
292,773 |
2.37 |
- |
|
| Alstodt Lance |
President, CEO, COB |
• • – |
2022-06-15 |
4 |
B |
$3.68 |
$2,578 |
D/D |
700 |
180,321 |
2.73 |
- |
|
| Kristal Robert Eugene |
Chief Financial Officer |
• – – |
2022-06-15 |
4 |
B |
$3.61 |
$700 |
D/D |
194 |
7,994 |
2.66 |
- |
|
| Alstodt Lance |
President, CEO, COB |
• • – |
2022-06-14 |
4 |
B |
$3.91 |
$1,956 |
D/D |
500 |
179,621 |
2.73 |
- |
|
| Silva Francisco |
VP of Research and Development |
• • – |
2022-06-14 |
4 |
A |
$3.78 |
$993 |
D/D |
263 |
162,114 |
|
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-06-13 |
4 |
B |
$3.92 |
$5,097 |
D/D |
1,300 |
291,573 |
2.37 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-06-10 |
4 |
B |
$4.23 |
$2,540 |
D/D |
600 |
290,273 |
2.37 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-06-09 |
4 |
B |
$4.27 |
$4,266 |
D/D |
1,000 |
289,673 |
2.37 |
- |
|
| Silva Francisco |
VP of Research and Development |
• • – |
2022-06-07 |
4 |
A |
$4.65 |
$2,627 |
D/D |
565 |
161,851 |
|
- |
|
| Kristal Robert Eugene |
Chief Financial Officer |
• – – |
2022-06-07 |
4 |
B |
$4.56 |
$912 |
D/D |
200 |
7,800 |
2.66 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-06-06 |
4 |
B |
$4.93 |
$14,798 |
D/D |
3,000 |
282,673 |
2.37 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-06-03 |
4 |
B |
$4.90 |
$5,879 |
D/D |
1,200 |
279,673 |
2.37 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-06-02 |
4 |
B |
$4.69 |
$4,688 |
D/D |
1,000 |
278,473 |
2.37 |
- |
|
| Alstodt Lance |
President, CEO, COB |
• • – |
2022-06-01 |
4 |
B |
$4.60 |
$920 |
D/D |
200 |
178,821 |
2.73 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-06-01 |
4 |
B |
$4.46 |
$41,122 |
D/D |
9,213 |
277,473 |
2.37 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-05-27 |
4 |
B |
$3.61 |
$39,592 |
D/D |
10,957 |
268,260 |
2.37 |
- |
|
| Alstodt Lance |
President, CEO, COB |
• • – |
2022-05-26 |
4 |
B |
$3.52 |
$9,494 |
D/D |
2,700 |
178,621 |
2.81 |
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-05-26 |
4 |
S |
$3.44 |
$6,876 |
D/D |
(2,000) |
257,303 |
|
- |
|
| Broadrick Dale |
10% Owner |
– – • |
2022-05-26 |
4 |
B |
$3.51 |
$17,364 |
D/D |
4,950 |
259,303 |
2.37 |
- |
|
| Alstodt Lance |
President, CEO, COB |
• • – |
2022-05-02 |
4 |
B |
$3.94 |
$1,579 |
D/D |
400 |
175,921 |
2.73 |
- |
|
| Kristal Robert Eugene |
Chief Financial Officer |
• – – |
2022-04-08 |
4 |
B |
$5.71 |
$43,396 |
D/D |
7,600 |
7,600 |
2.74 |
- |
|
212 Records found
|
|
Page 3 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.08 (6.35%) 
